Cargando…
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
The pandemic of novel coronavirus disease 2019 (COVID-19) has rampaged the world, with more than 58.4 million confirmed cases and over 1.38 million deaths across the world by 23 November 2020. There is an urgent need to identify effective drugs and vaccines to fight against the virus. Severe acute r...
Autores principales: | Hosseini, Maryam, Chen, Wanqiu, Xiao, Daliao, Wang, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928605/ https://www.ncbi.nlm.nih.gov/pubmed/33842834 http://dx.doi.org/10.1093/pcmedi/pbab001 |
Ejemplares similares
-
Anti-SARS drug screening by molecular docking
por: Wei, D.-Q., et al.
Publicado: (2006) -
Molecular docking-based computational platform for high-throughput virtual screening
por: Zhang, Baohua, et al.
Publicado: (2022) -
Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study
por: Eweas, Ahmad F., et al.
Publicado: (2022) -
Practical Considerations in Virtual Screening and Molecular Docking
por: Berry, Michael, et al.
Publicado: (2015) -
Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
por: Yu, Ran, et al.
Publicado: (2020)